mRNA vaccine

Interim data from an early-stage human trial outside China has showed Providence's shot PTX-COVID19-B was safe and produced strong…

Pre-clinical study provides evidence for improved immune responses with second-generation mRNA backbone jointly developed by…

The trial will assess antibody response in people who did not respond to two-dose regimen

It could be of use at a later stage all the more if the fight against variants was to continue, said the CEO

People who have recovered from the novel coronavirus infection may need only one shot as opposed to the recommended two jabs if…

Currently, there are 44 ongoing clinical trials exploring mRNA vaccines, of which 48 per cent are for oncology indications, where…

The main challenge for BNT-162b2 is the ultra-cold storage requirement of -80°C. The vaccine is likely to suffer poor uptake in…

Total of 200 million doses ordered by the US government to date, approximately 20 million doses will be delivered by the end of…

It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of…

FDA Advisory Committees provide non-binding recommendations, with the final decision on approval or authorisation to be made by…